| Jarrod Battles, AUD | |
|
11500 N Portland Ave, Oklahoma City, OK 73120-4625 | |
| (405) 548-4300 | |
| (405) 548-4349 |
| Full Name | Jarrod Battles |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 7 Years |
| Location | 11500 N Portland Ave, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871016956 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 4730 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hearts For Hearing Foundation | 8820195399 | 30 |
News Archive
Administration of antibiotics may have caused successive outbreaks of vancomycin-resistant enterococci in a Greek neonatal intensive care unit, according to a study in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.
Selexis SA ("Selexis") and NKT Therapeutics, Inc. ("NKTT") announce today that they have entered into a research services agreement whereby Selexis will screen antibody variants and generate high performance CHO-based production cell lines using their novel platform named INTEGRA-D2M(TM).
A new study identifies specific locations where medication and harm reduction services for people with opioid use disorder should be available in order to have the greatest impact on reducing opioid overdose deaths.
The study found that when a development gene named Hoxb1 worked in a mouse's brain but not in the developing facial tissues, nerves extended outward from the brain but failed to reach the facial muscles, leaving the mouse unable to blink its eyes, flatten its ears or make other facial movements.
› Verified 2 days ago
| Provider Name | Hearts For Hearing Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215006150 PECOS PAC ID: 8820195399 Enrollment ID: O20070517000246 |
News Archive
Administration of antibiotics may have caused successive outbreaks of vancomycin-resistant enterococci in a Greek neonatal intensive care unit, according to a study in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.
Selexis SA ("Selexis") and NKT Therapeutics, Inc. ("NKTT") announce today that they have entered into a research services agreement whereby Selexis will screen antibody variants and generate high performance CHO-based production cell lines using their novel platform named INTEGRA-D2M(TM).
A new study identifies specific locations where medication and harm reduction services for people with opioid use disorder should be available in order to have the greatest impact on reducing opioid overdose deaths.
The study found that when a development gene named Hoxb1 worked in a mouse's brain but not in the developing facial tissues, nerves extended outward from the brain but failed to reach the facial muscles, leaving the mouse unable to blink its eyes, flatten its ears or make other facial movements.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jarrod Battles, AUD 11500 N Portland Ave, Oklahoma City, OK 73120-4625 Ph: (405) 548-4300 | Jarrod Battles, AUD 11500 N Portland Ave, Oklahoma City, OK 73120-4625 Ph: (405) 548-4300 |
News Archive
Administration of antibiotics may have caused successive outbreaks of vancomycin-resistant enterococci in a Greek neonatal intensive care unit, according to a study in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.
Selexis SA ("Selexis") and NKT Therapeutics, Inc. ("NKTT") announce today that they have entered into a research services agreement whereby Selexis will screen antibody variants and generate high performance CHO-based production cell lines using their novel platform named INTEGRA-D2M(TM).
A new study identifies specific locations where medication and harm reduction services for people with opioid use disorder should be available in order to have the greatest impact on reducing opioid overdose deaths.
The study found that when a development gene named Hoxb1 worked in a mouse's brain but not in the developing facial tissues, nerves extended outward from the brain but failed to reach the facial muscles, leaving the mouse unable to blink its eyes, flatten its ears or make other facial movements.
› Verified 2 days ago
Mrs. Farris Ree Stroupe, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4140 W. Memorial Rd Suite 116, Oklahoma City, OK 73120 Phone: 405-755-1930 | |
Kristen Macdougall Bybee, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1200 Childrens Ave # 8c, Oklahoma City, OK 73104 Phone: 405-271-2662 | |
Kerri Anne Conley, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3400 Nw 56th St, Oklahoma City, OK 73112 Phone: 405-949-1906 | |
Dr. Elizabeth Ann Harder, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 535 Nw 9th St, Suite 305, Oklahoma City, OK 73102 Phone: 405-272-6027 | |
Ms. Esther H Kim, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 11500 N Portland Ave, Oklahoma City, OK 73120 Phone: 405-548-4300 Fax: 405-548-4349 | |
Dr. Elizabeth Ruth Elliott, AU.D., M.B.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-270-0501 Fax: 405-552-4365 | |
Jace A Wolfe, PHD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 11500 N Portland Ave, Oklahoma City, OK 73120 Phone: 405-548-4300 |